Unraveling the molecular heterogeneity in type 2 diabetes: a potential subtype discovery followed by metabolic modeling
Source check: Source checked. Not independent scientific confirmation.
Finding: Primary BMC Medical Genomics Results identify three T2DM expression clusters and distinct metabolic flux/gene patterns from 154 skeletal-muscle profiles; the earlier Research Square V1 reports the same three clusters and pathway result. These are computationally inferred subtypes, not clinically validated categories.
Technology: GA-SVM selects expression features; hierarchical clustering groups T2DM profiles and flux models characterize pathways.
Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
- AI contribution
- GA-SVM selects expression features; hierarchical clustering groups T2DM profiles and flux models characterize pathways.
- Test and result
- From 63 newly diagnosed T2DM and 91 controls, 26 genes classify groups at 94% repeated CV; three patient clusters show distinct expression/flux patterns.
- Limitation / still unknown
- Repeated internal CV for classification; metabolic mechanism inference is computational and no independent clinical cohort or experimental perturbation validates subtype biology.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://link.springer.com/article/10.1186/s12920-020-00767-0 · https://pubmed.ncbi.nlm.nih.gov/32831068/
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: linked separately.
Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.